Agenda

Faculty:

Pranshu Mohindra, MD
University Hospitals Seidman Cancer Center

Junzo Chino, MD
Duke University Medical Center

Mitchell Kamrava, MD
Cedars-Sinai Medical Center

Stella Lymberis, MD
NYU Langone

Henrike Westerveld, MD
Erasmus MC

Christine Fisher, MD, MPH
University of Colorado School of Medicine

Faculty:

Martin King, MD, PhD
Dana-Farber Cancer Institute

Joelle Helou, MD, MSc
London Regional Cancer Program

Peter Hoskin, MD, FRCP
Mount Vernon Cancer Centre

Peter J. Rossi, MD, FABS
Calaway Young Cancer Center at Valley View Hospitals

Marisa Kollmeier, MD
Memorial Sloan Kettering Cancer Center

Patrick W. McLaughlin, MD
University of Michigan Radiation Oncology Associates

Faculty:

Albert J. Chang, MD, PhD
UCLA Medical Center

Michael Garcia, MD, MS
GT Medical Technologies

Faculty:

Brett W. Cox, MD – ABS

Frank-Andre Siebert, PhD - GEC-ESTRO

Gaurav Bahl, MD – CBG

Manoj Gupta, MD – AROI

Umesh Mahantshetty, MD – IBS

Naoya Murakami, MD – JASTRO

Piotr Wojcieszek, MD – PBS

Joel Poder, PhD - ABG

Gustavo Sarria, MD – ALATRO

Moderator:

Peter Hoskin, MD, FRCP
Mount Vernon Cancer Centre

Faculty:

ADT Duration and Intensification with Brachytherapy Boost

Atsunori Yorozu, MD, PhD
NHO Tokyo Medical Center

Defining the DIL for Brachytherapy Boost

Cynthia Ménard, MD
CHUM

Role of Brachytherapy Boost in the FLAME/HypoFLAME Era

Alfonso Gómez-Iturriaga, MD, PhD
Hospital Universitario de Cruces, Biocruces Bizkaia Health Research Institute

Moderators:

Onyine Balogun, MD
Weill Cornell Medicine

Alina Sturdza, MD
Medical University of Vienna

Faculty:

Kayla Kafka-Peterson, BSN, RN
UCLA Health

Moderators:

Junzo Chino, MD
Duke University Medical Center

Allison M. Quick, MD
The Ohio State University, Wexner Medical Center

Faculty:

Molecular Subtypes of Uterine Cancer

Remi Nout, MD, PhD
Erasmus MC

Immunologic Effects/IO Combinations with Brachytherapy

Ann H. Klopp, MD, PhD
University of Texas MD Anderson Cancer Center

Customized Implants – Freehand and Non-Standard Implants

Elizabeth Kidd, MD
Stanford Cancer Institute Palo Alto

Automated and Adapted Treatment Planning

Luc Beaulieu, PhD, FABS
Université Laval

Moderators:

Joelle Helou, MD, MSc
London Regional Cancer Program

Noelia Sanmamed, MD
Hospital Clínico San Carlos

Faculty:

Kayla Kafka-Peterson, BSN, RN
UCLA Health

Moderator:

Parag Sanghvi, MD, MSPH
University of California, San Diego

Faculty:

How to Start a Skin Brachytherapy Program and Deliver Treatment: Indications, Techniques and Advances

Adam Chichel, MD, PhD
Greater Poland Cancer Centre - Brachytherapy

Efficacy, Fractionation and Dosing for Skin Brachytherapy

Anupam Rishi, MD
Moffitt Cancer Center

Dosimetric Comparison on EBRT vs. Brachytherapy

Jennifer Steers, PhD
Cedars-Sinai Medical Center

Technical Report and Consensus Standards

Víctor González Pérez, PhD
Fundación Instituto Valenciano de Oncología

Moderators:

Andrew Keller, MD
AdventHealth Cancer Insitute

Peter Niehoff, MD
Sana Klinikum Offenbach

Faculty:

The Status of Brachytherapy Education in America, Asia and Europe

Jill Remick, MD
Winship Cancer Institute, Emory University

Alina Sturdza, MD
Medical University of Vienna

The View from a Young Resident or Brachytherapy Specialist

Rebecca Krc, DO
University of Maryland Medical Center

Katharina Brück, MD
Amsterdam University Medical Center

Moderators:

Cristina Gutiérrez Miguélez, MD
Institut Català d'Oncologia

Jean-Michel Hannoun-Levi, MD, PhD
Antoine Lacassagne Cancer Centre – University Côte d’Azur

Faculty:

u/vAPBI

Marta Gimeno-Morales, MD, PhD
Cancer Center Clínica Universidad de Navarra

Salvage

Bridget Quinn, MD, PhD
VCU Medical Center

MIBT

Johann Tang, MD
ME Novena Specialist Group

Single Entry Devices

Cathryn M. Yashar, MD, FABS
University of California, San Diego

Faculty:

Introduction

John Kowal, President AMS ROS
Varian, a Siemens Healthineers Company

Adapting to the Surface with Skin HDR

Andrew Farach, MD
Houston Methodist Hospital

Focal Therapy: Vitesse Real-Time HDR Prostate

Timothy Showalter, MD, MPH
University of Virginia Hospital Emily Couric Clinical Cancer Center

Using your Interstitial Cylinder to Adapt to the Target

Diana-Cristina Pop, PhD
Institutul Oncologic Cluj-Napoca

Developing Advanced Brachytherapy in Southeast Asia

Pittaya Dankulchai, MD
Medicine Siriraj Hospital

Sushil Beriwal MD, MBA, FABS
Allegheny Health Network
Varian, a Siemens Healthineers Company

Moderators:

Arthur Sun Myint, FRCP (Ed), DMRT
The Clatterbridge Cancer Centre, NHS Foundation Trust

Te Vuong, MD
McGill University

Faculty:

Contact Brachytherapy and the Opera Trial

Alexandra Stewart, MD
Royal Surrey Hospital, Royal Surrey Cancer Center

HDR Brachytherapy and Morpheus Trial

Te Vuong
McGill University

Comparative Dosimetry for Rectal Brachytherapy

Nikolaos Tselis, MD
University Hospital Frankfurt

Moderator:

Deidre Batchelar, PhD
British Columbia Cancer Agency-Kelowna

Faculty:

Treatment Planning

Frank-André Siebert, PhD
UKSH, Campus Kiel

Applications

Deidre Batchelar, PhD
British Columbia Cancer Agency-Kelowna

Imaging Systems

Donna Murrell, PhD
Western University; London Regional Cancer Program

Moderators:

Catheryn Yashar, MD, FABS
University of California, San Diego

Einsley Janowski, MD
University of Virginia

Faculty:

IORT Clinical Results

Evelyn Martinez, MD
Institut Català d'Oncologia

50-kV IORT: Pros

William Small, MD
Stritch School of Medicine, Loyola University

50-kV IORT: Cons

Vratislav Strnad, MD
University Hospital Erlangen

Moderators:

Marjory Jolicoeur, MD
Université de Montréal - Hôpital Charles Lemoyne

Luca Tagliaferri, MD
Policlinico Universitario Agostino Gemell

Faculty:

Focus on Anal Canal Cancer

Luca Tagliaferri, MD
Policlinico Universitario Agostino Gemell

Focus on Oropharyngeal Cancers

Ashwini Budrukkar, MD
Tata Memorial Hospital

Focus on Nasal Vestibule

Francesco Bussu, MD
Università degli Studi di Sassari

Moderator:

Mahta Mirzaei McKee, PhD, FABS
Wake Forest University

Faculty:

US Perspective

Mahta Mirzaei McKee, PhD, FABS
Wake Forest University

EU Perspective

Jacob G. Johansen, PhD
Aarhus University

IAEA Perspective

Mauro Carrara
IAEA

Moderator:

Bethany M. Anderson, MD
University of Wisconsin

Faculty:

Practical Integrative Oncology for the Brachytherapist

Matthew McCurdy, MD, PhD
Society of Integrative Oncology

Moderators:

Ashwini Budrukkar, MD
Tata Memorial Hospital

Baho Sidiqi, MD
Northwell Health

Moderators:

Åsa Carlsson Tedgren, PhD
Linkoping University

Joel Poder, PhD
St George Hospital Cancer Care Centre

Moderators:

Bridget Quinn, MD, PhD
VCU Health

Marta Gimeno-Morales, MD, PhD
Universidad de Pamplona

Moderators:

Nitika Thawani,MD
Dignity Health

Michael Trager, MS
Northwell Health

Moderators:

Idalid “Ivy” Franco, MD
Dana-Farber Cancer Institute

Shauna M. McVorran, MD
Dartmouth Hitchcock Medical Center and Clinic

Faculty:

Real World Experiences with Rectal Spacing

Jonathan Tward, MD
Univ. of Utah - Huntsman Cancer Institute

Trial Investigator - BioProtect Pivotal Trial Experience & Evidence

Danny Song, MD
Johns Hopkins

Learnings From the First 300 BioProtect Cases - "How I Do It."

Shawn Zimberg, MD
Advanced Radiation Centers - Solaris Health

Speaker:

John Jenson

Moderator:

Gregory Merrick MD, FABS
URI

Faculty:

Megan Kassick, MD, MPH
University of Pennsylvania Perelman School of Medicine

Mira Keyes, MD, FABS
British Columbia Cancer Agency

Martin King, MD, PhD
Dana-Farber Cancer Institute

Moderators:

Megan Kassick, MD, MPH
University of Pennsylvania Perelman School of Medicine

Manon Kissel, MD
Institut Curie

Faculty:

SAVE Trial

Gita Suneja, MD
University of Utah Health

EMBRACE II

Kari Tanderup, PhD
Aarhus University Hospital

Retro-COSMOS

Supriya Chopra, MD
Tata Memorial Centre

EMBRAVE

Remi Nout, MD, PhD
Erasmus MC

Moderators:

Martin T. King, MD, PhD
Dana-Farber Cancer Institute

Steven Frank, MD, FABS
University of Texas MD Anderson Cancer Center

Faculty:

Radiation Oncologist perspective: EU

Piotr Wojcieszek, MD
Maria Sklodowska Curie Memorial Cancer

Radiation Oncologist Perspective: US

Peter F. Orio, III, DO, MS, FABS
Dana-Farber Cancer Institute

Radiation Oncologist Perspective: AUS

Jeremy Millar, MD
Alfred Health

Moderators:

Frank-André Siebert, PhD
UKSH, Campus Kiel

Vratislav Strnad, MD
University Hospital Erlangen

Faculty:

Overview of Artificial Intelligence in Brachytherapy

Susovan Banerjee, MD
Medanta The Medicity

Deep learning Assisted Algorithm for Catheter Reconstruction During MR-Only GYN Interstitial Brachytherapy

Ananth Ravi, MD
Sunnybrook Odette Cancer Centre

Artificial Intelligence-Generated vs. Clinical Prostate Contours for US-Based HDR Brachytherapy

Daniel Rosen, MD
Dana-Farber Cancer Institute

AI in Brachytherapy Treatment Planning Systems

Bradley Pieters, MD, PhD
University of Amsterdam Medical Centre

Moderator:

Maarten ter Mors
SVP and Head of Global Brachytherapy Solutions Elekta

Panelists:

Doris Brown, MD, PhD
Atrium Health Wake Forest Baptist Hospital

Paul Black, PhD
Atrium Health Wake Forest Baptist Hospital

Dr. Federica Gherardi, Radiotherapist
Istituto Nazionale Tumori Pascale

Firas Mourtada, MSE, PhD, DABR
Thomas Jefferson University Hospital

Faculty:

A Randomized Comparison Of LDR Or HDR Brachytherapy Boost Combined With Pelvic External Beam Radiation For Unfavorable Intermediate Or High-risk Prostate Cancer. Efficacy Results At Median 6 Years Follow Up

Jui Chih Cheng, MD
University of British Columbia

Design, Construction, And Validation Of An Electromagnetic Tracking-based Guidance System For Assisted Placement Of Interstitial Brachytherapy Applicators

Christopher Deufel, PhD
Mayo Clinic

Cervical Cancer Brachytherapy In Botswana: A 12-year Global Collaboration Journey

Memory Bvochora-Nsingo, MD
Gaborone Private Hospital

Prospective Evaluation Of Supplemental External Beam Radiotherapy In Higher - Risk Prostate Cancer Patients Implanted With Pd-103 : Long - Term Results Of The 44/20/0 Trials

Gregory Merrick, MD, FABS
URI

Long-Term Late Side-Effects After Breast Conserving Surgery And Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation Using Multicatheter Brachytherapy - 10-Year Update Of The GEC-ESTRO Multicentric Phase 3 Trial

Csaba Polgar, MD
National Institute of Oncology

Moderators:

Moderators:

Melissa Joyner, MD
University of Texas MD Anderson Cancer Center

Alina Sturdza, MD
Medical University of Vienna

Faculty:

The European View

Peter Niehoff, MD
San Klinkum Offenbach

The American View: North and South America

Catheryn M. Yashar, MD, FABS
University of California, San Diego

The Asian and Australian View

Pittaya Dankulchai, MD
Medicine Siriraj Hospital

The Middle East and African View

Noha Jastaniyah, MD
King Faisal Specialist Hospital

Moderator:

Andrew Farach, MD
Houston Methodist Hospital

Faculty:

Developing New Models for Prostate Brachytherapy Practice

Steven Kurtzman, MD
Western Radiation Oncology

Practice Building 101: What Elements are Required to Build a Brachytherapy Practice?

Jyoti Mayadev, MD
University of California, San Diego

Budget Considerations and Generating Support from Hospital Leadership at an Academic Center

Akila Viswanathan, MD, FABS
John Hopkins Medicine

Moderators:

Neil Taunk, MD
Hospital of the University of Pennsylvania

Jacqueline E. Zoberi, PhD
Washington University School of Medicine

Faculty:

Mallika Marar, MD
Stanford Medicine

Justin Mikell, PhD
Washington University in St. Louis

Daniel Kim, MD
Inova Scharr Cancer Institute

Moderator:

Åsa Carlsson Tedgren, PhD
Linkoping University

Faculty:

Model Based Dose Calculations

Åsa Carlsson Tedgren, PhD
Linkoping University

In-Vivo Dosimetry

Luc Beaulieu, PhD, FABS
Université Laval

Applicator Tracking

Joel Poder, PhD
St George Hospital Cancer Care Centre

Moderators:

Vratislav Strnad, MD
University Hospital Erlangen

Puja Venkat, MD
UCLA Health

Moderator:

Katherine Tzou, MD
University of Colorado

Stefanie Corradini, MD
University Hospital Ludwig-Maximilians-University of Munich

Faculty:

CBG Case: Vaginal Cancer/Vaginal Recurrence

Eric Leung, MD
Sunnybrook Health Sciences Center

Vulvar Preservation

Marjory Jolicoeur, MD
Université de Montréal - Hôpital Charles Lemoyne

IBS Case: Optimal Cervical Brachytherapy in Resource-Limited Environment

Umesh Mahantshetty, MD
Tata Memorial

Bladder Involvement – Fistula Management

Neil Taunk, MD
Hospital of the University of Pennsylvania

Moderators:

Joseph Bucci, MD
St George Public Hospital Cancer Care Centre, Kogarah, Sydney

Juanita Crook, MD, FABS
British Columbia Cancer Agency

Faculty:

Selecting Optimal Monotherapy Regimen (LDR, HDR, SBRT)

Joelle Helou, MD, MSc
London Regional Cancer Program

Brachytherapy Monotherapy for Unfavorable Risk Disease

Martin King, MD, PhD
Dana-Farber Cancer Institute

Salvage Brachytherapy: Whole-Gland vs. Focal

Adam Kluska, MD
Greater Poland Cancer Center

Moderators:

Arjit Baghwala, MS
Houston Methodist Hospital

Bruce Libby, PhD
Moffit Cancer Center

Moderators:

Ángeles Rovirosa, MD, PhD
Hospital Clínic de Barcelona

Naoya Murakami, MD, PhD
Juntendo University Hospital

Moderators:

Mitchell Kamrava, MD
Cedars-Sinai Medical Center

Iosif Strouthos, MD
German Oncology Center

Moderators:

Junzo Chino, MD
Duke Cancer Center

Pranshu Mohindra, MD
University Hospitals Seidman Cancer Center

Moderators:

Juanita Crook, MD, FABS
British Columbia Cancer Agency

Arun Goel, MD
University of Pennsylvania